Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study
Objective: Cognitive impairment is one of the core symptoms of schizophrenia, which is stable and lifelong. L-carnitine has been shown to improve cognitive function and decrease the rate of cognitive deterioration in patients with Alzheimer's disease. However, it remains unclear regarding the r...
Guardat en:
Autors principals: | , , , , , |
---|---|
Format: | Llibre |
Publicat: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Còpia 1 | Disponible |